Consensus EQUINOX NEPREMICNINE d.d.

Equities

EQNX

SI0031117813

End-of-day quote Ljubljana S.E. Other stock markets 06:00:00 2024-06-11 pm EDT			5-day change	1st Jan Change
57 ^EUR	+0.88%		+0.88%	+8.57%

2022	An unknown buyer acquired an unknown minority stake in EQUINOX NEPREMICNINE d.d. from Axor holding d.d.	CI
2022	EQUINOX NEPREMICNINE d.d. has completed an IPO.	CI

Evolution of the average Target Price on EQUINOX NEPREMICNINE d.d.

Price target over the last 5 years

History of analyst recommendation changes

86583fdf6cb71fbce4b.sqNi36aXvfb_aQflJnkIKEmXWrem3n6_Lr8smrHS7GI.0Zc0q8-kisapKlTcZC9JSh3nHdCe7TTebZJPyvL_njj7jjrukcfRm9IlPw~fb7584aac89ced2b7b20b28514da67cc

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57 EUR

Average target price

63.5 EUR

Spread / Average Target

+11.40%

High Price Target

63.5 EUR

Spread / Highest target

+11.40%

Low Price Target

63.5 EUR

Spread / Lowest Target

+11.40%

Consensus detail

Consensus revision (last 18 months)

Annual profits - Rate of surprise

Company calendar